EGFR and cancer: Ligand activation of EPHA2 or EPHA2 knockdown by small interfering RNA inhibited EGF-induced cell motility of EGFR-overexpressing human cancer cells, indicating a functional role of EPHA2 in EGFR-expressing cancer cells [19].